Cargando…
Early treatment of rituximab combined with eltrombopag for secondary thrombocytopenic purpura in rheumatoid arthritis: A case report
RATIONALE: Secondary immune thrombocytopenic purpura (ITP) is also known as acquired thrombocytopenic purpura, autoimmune disease is usually one of the important causes. There are few reports about treatment of refractory thrombocytopenic purpura in rheumatoid arthritis (RA). We report a case of ref...
Autores principales: | Zhang, Naidan, Ji, Chaixia, Bao, Xiao, Yuan, Chengliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757979/ https://www.ncbi.nlm.nih.gov/pubmed/35029180 http://dx.doi.org/10.1097/MD.0000000000028417 |
Ejemplares similares
-
Development and assessment of a predictive model for early diagnosis of rheumatoid arthritis in southwest China: A new nomogram
por: Zhang, Naidan, et al.
Publicado: (2023) -
Steroid-Refractory Chronic Idiopathic Thrombocytopenic Purpura Responding to Combination Therapy With Eltrombopag and Rituximab
por: Ahmed, Mohanad, et al.
Publicado: (2020) -
Successful treatment of thrombotic thrombocytopenic purpura with plasmapheresis and anti-CD20 antibodies in a patient with immune thrombocytopenia and systemic lupus erythematosus: Case report
por: Jung, Ju-Yang, et al.
Publicado: (2022) -
Treatment of immune thrombocytopenic purpura: focus on eltrombopag
por: Rice, Lawrence
Publicado: (2009) -
Biologic therapy for amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy: Case report and review of literature
por: Jung, Ju-Yang, et al.
Publicado: (2021)